We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Further to previous announcement regarding the proposed reverse take-over of medicinal cannabis company Apollon Formularies Ltd ("Apollon") (the "RTO" or the "Proposed Acquisition") on 23 February 2021, AfriAg is pleased to announce today the posting of its admission document and notice of general meeting to be held at 7-9 Swallow Street, London, United Kingdom, W1B 4DE at 10 a.m. (London Time) on 12 April 2021.
Chirping we hear?
Good find Andrew REC............
Wonder if the old BOD sold already?
http://www.afriagglobal.com/wp-content/uploads/2021/03/Apollon_Acquisition-FINAL.pdf
The new company will list on Aquis on the 13 April 2021.
12 month lock in period for the new BOD and Apollon shareholders.
Dozens of patients have applied for herbal cannabis prescriptions within hours of the first private clinic opening in Scotland.
https://www.thetimes.co.uk/article/high-demand-as-scotlands-first-cannabis-clinic-opens-qdtskrwv3
https://www.bbc.co.uk/news/uk-scotland-tayside-central-56475596
Apollon Formularies
@apollon_uk
·
43m
It's great to see Scotland's first #MedicalCannabis centre, set up by
@SapphireClinics
, receiving high demand since opening yesterday, showing changing and positive attitude towards cannabis as an alternative treatment. Read more here...
Apollon Formularies CEO Dr. Stephen Barnhill:
"Our conditional fundraise of £2,500,000, as announced on 23 February, has shown a strong appetite for our company and we are pleased that we are able to provide the market with a truly unique investment opportunity.”
Apollon Formularies
@apollon_uk
·
52m
Leading the teams in both London and Jamaica is Apollon's CEO, Dr. Stephen Barnhill. Dr. Barnhill is a medical doctor with over 35 years experience of of running both private and publicly traded biotech companies #Apollon #MedicalCannabis #THC
Apollon Formularies
@apollon_uk
·
8m
Apollon’s strong research and development ability will make us one of the few listed cannabis companies in Europe that is able to treat patients with formulas inclusive of THC, and licences held in Jamaica mean that all our formulas are backed by medically supervised treatments.
Apollon Formularies
@apollon_uk
·
10m
Apollon’s strong research and development ability will make us one of the few listed cannabis companies in Europe that is able to treat patients with formulas inclusive of THC, and licences held in Jamaica mean that all our formulas are backed by medically supervised treatments.
Apollon Formularies
@apollon_uk
·
8m
Apollon’s strong research and development ability will make us one of the few listed cannabis companies in Europe that is able to treat patients with formulas inclusive of THC, and licences held in Jamaica mean that all our formulas are backed by medically supervised treatments.
Apollon Formularies
@apollon_uk
·
15m
CEO Dr. Stephen Barnhill:
“We are delighted to be coming to market at such an important time for medical cannabis across the UK.
We look forward to bringing Apollon, with its full suite of licences and THC inclusive formulations, to the London market.
Let the news flow post April 12th
Will be great once the Apollon team get the handover.
This is the only company thats licence fort THC and that R&D licence, well thats what will get us taken out.
Buy well all and HODL!
I reckon this is going places.
Aim? Apollon - second round of fundraising to happen within 2021.
New products should do the same here...........IMHO
You and I we're vindicated letting off steam. Let the record show...............
Over the counter gel..................
Market Summary > Futura Medical plc.
LON: FUM
50.00 GBX +32.00 (177.78%)
19 Mar, 16:25 GMT · Disclaimer
Think the Doc will take us onto AIM and maybe a listing over the water, something that Lenigas failed to do. IMHO
Reading that AJ Bell will be allowing electronic trading on Aquis. May look to open an account with them unless Interactive Investors get their act together.
Hi Kenny, yes your description is probably more apt.
As you say, there will probably be a lot more interest once the new BOD is in control and we have the change of name and epic code. It is beginning to sound that the big retail brokers are moving to online trading with Aquis, which should certainly increase liquidity.
Andrew IMHO we will start to see more trades once the three musketeers as you call them leave.
Avarice if you ask me.......................
Volume reads.................
38,154